Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967836 · ClinicalTrials.gov registry record · NA
Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients
A NA study of Cancer-related Problem/Condition and Ambulatory Care, sponsored by Maureen T Greene.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 4
- Study locations
NCT01967836: Completed NA study of Cancer-related Problem/Condition and Ambulatory Care, sponsored by Maureen T Greene.
NCT01967836 is a NA study of Cancer-related Problem/Condition and Ambulatory Care that has completed, run by Maureen T Greene. The registered enrollment target is 11 participants, below the 113-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01967836, a NA study of Cancer-related Problem/Condition and Ambulatory Care, has completed, sponsored by Maureen T Greene.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to see if Glad Press 'n Seal works as a moisture barrier for central line that is left in place during ambulatory oncology clinical care.
Primary Outcome
Percentage of responses to evaluation questions (Percentage reported are "yes" responses) for the following questions. 40 surveys were returned from 11 patient subjects. 1. Did you need assistance to place the Glad Press 'n Seal to your IV area? 2. Was the area covered by the Glad Press 'n Seal dry after taking it off? 3. Was the dressing covering your IV undamaged after taking off the Glad Press 'n Seal? 4. Did you feel the IV Line was accidentally pulled at all with the use of the Glad Press
Conditions Studied
Interventions
- DEVICE Glad Press 'n Seal
Study Locations (4)
Wisconsin
- Rieman Cancer Center - Milwaukee
- Wheaton Franciscan Healthcare-St Joseph campus - Milwaukee
- WFH-St. Francis - Milwaukee
- Wheaton Franciscan - Wauwatosa Campus - Wauwatosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01967836 record still lists
NCT01967836 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 113-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 1 intervention - of which Glad Press 'n Seal is the first listed.
NCT01967836 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01967836 about?
NCT01967836 is a clinical study titled "Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients". The purpose of this study is to see if Glad Press 'n Seal works as a moisture barrier for central line that is left in place during ambulatory oncology clinical care.
What is the current status of trial NCT01967836?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-10. Estimated completion is 2015-04.
What conditions does trial NCT01967836 study?
This clinical trial studies the following conditions: Cancer-related Problem/Condition, Ambulatory Care.
What interventions are being tested in trial NCT01967836?
The interventions under investigation include: Glad Press 'n Seal (DEVICE).
Who is sponsoring clinical trial NCT01967836?
This trial is sponsored by Maureen T Greene, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01967836 being conducted?
This trial has 4 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer-related Problem/Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01967836's enrollment target sits among peer trials
11 11th of 10 the lowest of 10 other Cancer-related Problem/Condition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer-related Problem/Condition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
RECRUITING · NA
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Virtual Exercise Program to Reduce Cancer Related Fatigue
ACTIVE NOT RECRUITING · NA
-
Systematic Light Exposure for Fatigue in Breast Cancer Patients
COMPLETED · NA
-
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
COMPLETED · NA
-
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia